EGFR and hepatocellular carcinoma: In hepatocellular carcinoma, lnc-EGFR promotes immune evasion by stabilizing the EGFR protein, which enhances the downstream AP-1/NF-AT1 signaling pathway and drives Treg differentiation (Jiang et al., 2017).